Study Provides Hope That Some Transplant Patients Could Live Free of Anti-Rejection Drugs, Packard/Stanford University School of Medicine Researchers Say

STANFORD, Calif. — People with organ transplants, resigned to a lifetime of anti-rejection drugs, may now have reason to hope for a respite, say researchers at Lucile Packard Children’s Hospital and the Stanford University School of Medicine. Using a simple blood sample, the scientists have identified for the first time a pattern of gene expression shared by a small group of patients who beat the odds and remained healthy for years without medication.